Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Open-Label Safety Extension Study of Avonex

This study has been completed.
Information provided by:
Biogen Identifier:
First received: June 5, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2003
  Primary Completion Date: June 2003 (Final data collection date for primary outcome measure)